Literature DB >> 11796635

HLA-B*35-restricted CD8(+)-T-cell epitope in Mycobacterium tuberculosis Rv2903c.

Michèl R Klein1, Abdulrahman S Hammond, Steve M Smith, Assan Jaye, Pauline T Lukey, Keith P W J McAdam.   

Abstract

Few human CD8(+) T-cell epitopes in mycobacterial antigens have been described to date. Here we have identified a novel HLA-B*35-restricted CD8(+) T-cell epitope in Mycobacterium tuberculosis Rv2903c based on a reverse immunogenetics approach. Peptide-specific CD8 T cells were able to kill M. tuberculosis-infected macrophages and produce gamma interferon and tumor necrosis factor alpha.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11796635      PMCID： PMC127663          DOI： 10.1128/IAI.70.2.981-984.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  21 in total

1.  T-cell epitope mapping by flow cytometry.

Authors:  F Kern; I P Surel; C Brock; B Freistedt; H Radtke; A Scheffold; R Blasczyk; P Reinke; J Schneider-Mergener; A Radbruch; P Walden; H D Volk
Journal:  Nat Med       Date:  1998-08       Impact factor: 53.440

2.  Optimization of a peptide-based protocol employing IL-7 for in vitro restimulation of human cytotoxic T lymphocyte precursors.

Authors:  A Lalvani; T Dong; G Ogg; A A Patham; H Newell; A V Hill; A J McMichael; S Rowland-Jones
Journal:  J Immunol Methods       Date:  1997-12-15       Impact factor: 2.303

3.  An HLA class I peptide-binding assay based on competition for binding to class I molecules on intact human B cells. Identification of conserved HIV-1 polymerase peptides binding to HLA-A*0301.

Authors:  S H van der Burg; E Ras; J W Drijfhout; W E Benckhuijsen; A J Bremers; C J Melief; W M Kast
Journal:  Hum Immunol       Date:  1995-12       Impact factor: 2.850

4.  Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains.

Authors:  K C Parker; M A Bednarek; J E Coligan
Journal:  J Immunol       Date:  1994-01-01       Impact factor: 5.422

5.  Immunogenicity of peptides bound to MHC class I molecules depends on the MHC-peptide complex stability.

Authors:  S H van der Burg; M J Visseren; R M Brandt; W M Kast; C J Melief
Journal:  J Immunol       Date:  1996-05-01       Impact factor: 5.422

6.  HLA-B*3501-peptide interactions: role of anchor residues of peptides in their binding to HLA-B*3501 molecules.

Authors:  Y Takamiya; C Schönbach; K Nokihara; M Yamaguchi; S Ferrone; K Kano; K Egawa; M Takiguchi
Journal:  Int Immunol       Date:  1994-02       Impact factor: 4.823

7.  Human cytolytic and interferon gamma-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis.

Authors:  A Lalvani; R Brookes; R J Wilkinson; A S Malin; A A Pathan; P Andersen; H Dockrell; G Pasvol; A V Hill
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-06       Impact factor: 11.205

8.  Crystal structure of a bacterial signal peptidase in complex with a beta-lactam inhibitor.

Authors:  M Paetzel; R E Dalbey; N C Strynadka
Journal:  Nature       Date:  1998-11-12       Impact factor: 49.962

9.  Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence.

Authors:  S T Cole; R Brosch; J Parkhill; T Garnier; C Churcher; D Harris; S V Gordon; K Eiglmeier; S Gas; C E Barry; F Tekaia; K Badcock; D Basham; D Brown; T Chillingworth; R Connor; R Davies; K Devlin; T Feltwell; S Gentles; N Hamlin; S Holroyd; T Hornsby; K Jagels; A Krogh; J McLean; S Moule; L Murphy; K Oliver; J Osborne; M A Quail; M A Rajandream; J Rogers; S Rutter; K Seeger; J Skelton; R Squares; S Squares; J E Sulston; K Taylor; S Whitehead; B G Barrell
Journal:  Nature       Date:  1998-06-11       Impact factor: 49.962

10.  Characterization of human Mycobacterium bovis bacille Calmette-Guérin-reactive CD8+ T cells.

Authors:  S M Smith; A S Malin; T Pauline; S E Atkinson; J Content; K Huygen; H M Dockrell
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441
View more
  6 in total

1.  Mycobacterium tuberculosis genome-wide screen exposes multiple CD8 T cell epitopes.

Authors:  A S Hammond; M R Klein; T Corrah; A Fox; A Jaye; K P McAdam; R H Brookes
Journal:  Clin Exp Immunol       Date:  2005-04       Impact factor: 4.330

2.  Highly differentiated, resting gn-specific memory CD8+ T cells persist years after infection by andes hantavirus.

Authors:  Tobias Manigold; Andrés Mori; Rebecca Graumann; Elena Llop; Valeska Simon; Marcela Ferrés; Francisca Valdivieso; Constanza Castillo; Brian Hjelle; Pablo Vial
Journal:  PLoS Pathog       Date:  2010-02-19       Impact factor: 6.823

3.  Identification of CD8 T-lymphocyte epitopes in OmpB of Rickettsia conorii.

Authors:  Zhen Li; C Marcela Díaz-Montero; Gustavo Valbuena; Xue-Jie Yu; Juan P Olano; Hui-Min Feng; David H Walker
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

4.  Analysis of Mycobacterium tuberculosis-specific CD8 T-cells in patients with active tuberculosis and in individuals with latent infection.

Authors:  Nadia Caccamo; Giuliana Guggino; Serena Meraviglia; Giuseppe Gelsomino; Paola Di Carlo; Lucina Titone; Marialuisa Bocchino; Domenico Galati; Alessandro Matarese; Jan Nouta; Michel R Klein; Alfredo Salerno; Alessandro Sanduzzi; Francesco Dieli; Tom H M Ottenhoff
Journal:  PLoS One       Date:  2009-05-13       Impact factor: 3.240

5.  Immunodominant tuberculosis CD8 antigens preferentially restricted by HLA-B.

Authors:  Deborah A Lewinsohn; Ervina Winata; Gwendolyn M Swarbrick; Katie E Tanner; Matthew S Cook; Megan D Null; Meghan E Cansler; Alessandro Sette; John Sidney; David M Lewinsohn
Journal:  PLoS Pathog       Date:  2007-09-21       Impact factor: 6.823

6.  Human CD8+ T cells from TB pleurisy respond to four immunodominant epitopes in Mtb CFP10 restricted by HLA-B alleles.

Authors:  Li Li; Binyan Yang; Sifei Yu; Xianlan Zhang; Suihua Lao; Changyou Wu
Journal:  PLoS One       Date:  2013-12-12       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.